Skip to content
In Stock Allopurinol
Gout

Allopurinol

Allopurinol lowers uric acid production by blocking xanthine oxidase, an enzyme involved in purine metabolism. It is used for adults with chronic gout, recurrent uric acid kidney stones, or…

Guaranteed quality Original product
Delivery: from 4 days Discreet shipping
24/7 Support Always available
Active ingredient: Allopurinol
Select dosage:
Select pack Package Per unit Price
$ 2.97 $ 178.00
$ 2.69 $ 267.00 $ 242.08 Save 9%
$ 2.52 $ 356.00 $ 302.60 Save 15%
Free Regular Delivery $ 2.37 $ 534.00 $ 427.20 Save 20%
Free Express Delivery $ 2.29 $ 801.00 $ 617.66 Save 23%
Best value Free Express Delivery $ 2.24 $ 1,068.00 $ 806.34 Save 25%
$ 4.98 $ 149.52
$ 4.57 $ 299.04 $ 274.12 Save 8%
Free Regular Delivery $ 4.49 $ 448.56 $ 404.06 Save 10%
Free Regular Delivery $ 4.12 $ 598.08 $ 494.84 Save 17%
Free Express Delivery $ 3.83 $ 897.12 $ 688.86 Save 23%
Best value Free Express Delivery $ 3.70 $ 1,794.24 $ 1,333.22 Save 26%

Free delivery on orders from $ 356.00, free express delivery from $ 534.00

Secure payment methods:
VISA AMEX JCB DISCOVER

Allopurinol lowers uric acid production by blocking xanthine oxidase, an enzyme involved in purine metabolism. It is used for adults with chronic gout, recurrent uric acid kidney stones, or treatment-related hyperuricaemia. Regular use helps prevent urate crystal formation, although it does not provide immediate relief during an acute gout attack.

Product information

Allopurinol belongs to the xanthine oxidase inhibitor class. Its active substance is allopurinol, supplied as oral tablets.

Ingredients

Allopurinol contains the active substance allopurinol and belongs to the xanthine oxidase inhibitor class. It is supplied as oral tablets.

Therapeutic indications

Allopurinol is used when uric acid production needs to be reduced over an extended period. The main clinical applications include chronic gout prevention, selected uric acid stone disorders, and prevention of excessive uric acid production during some cancer treatments.

Condition Clinical goal Typical treatment role
Chronic gout Reduce serum urate and prevent crystal deposition Long-term prevention
Uric acid kidney stones Reduce uric acid available for stone formation Preventive treatment
Tumour lysis syndrome risk Limit uric acid formation after rapid cell breakdown Specialist prophylaxis

Prevention of Urate Crystal Deposition in Gout

Gout develops when urate crystals trigger inflammation inside or around a joint. Allopurinol lowers the biochemical source of those crystals, helping prevent future attacks and reducing the risk of progressive joint damage when serum urate remains controlled.

During chemotherapy, rapid destruction of tumour cells can release large amounts of purines into the blood. Tumour lysis syndrome may then produce a sharp rise in uric acid, which can contribute to acute kidney injury. Allopurinol may be used as prophylaxis in this setting under hospital or oncology supervision [2].

Calcium oxalate stones can also occur alongside high urinary uric acid. In selected patients, reducing uric acid production can support a broader kidney-stone prevention plan. Hydration, urine testing, dietary measures, and treatment of other risk factors remain relevant.

Directions for use

  • Allopurinol is taken regularly by mouth as oral tablets to lower uric acid production and help prevent urate crystal formation.
  • It is used over an extended period for chronic gout, recurrent uric acid kidney stones, or treatment-related hyperuricaemia, including specialist prophylaxis when rapid cell breakdown increases uric acid production.
  • Take the prescribed regimen consistently. Allopurinol does not provide immediate relief during an acute gout attack.
  • If a dose is missed, take it when remembered unless the next scheduled dose is close; do not take two doses together.

When not to use it

  • previous Stevens–Johnson syndrome or toxic epidermal necrolysis;
  • known HLA-B*58:01 positivity;
  • active liver disease;
  • significant renal impairment;
  • use of azathioprine or mercaptopurine;
  • pregnancy or breastfeeding;
  • previous severe reaction to a medicine;
  • unexplained blood-count abnormalities.

When this is not for you

Allopurinol is not for everyone. This medication is not for you if you have previously experienced a serious hypersensitivity reaction to allopurinol or a related metabolite. It also requires specialist assessment when kidney function is reduced, when severe liver disease is present, or when interacting medicines are being used.

Unwanted effects

Mild effects can include nausea, loose stools, headache, drowsiness, or skin irritation. Taking the tablet after food may reduce stomach discomfort for some people, provided this fits the prescribed instructions. Persistent vomiting or diarrhoea matters because dehydration can place extra strain on the kidneys.

The most serious concern is a hypersensitivity reaction. It is uncommon, but its consequences can be severe. A rash with fever, facial swelling, mucosal sores, blistering, or peeling requires urgent assessment and stopping further doses until a clinician provides direction.

Other clinically significant reactions can include:

  • abnormal liver tests or hepatitis;
  • reduced blood-cell counts;
  • worsening kidney function;
  • severe allergic swelling;
  • severe skin reactions involving blistering or tissue loss.

A mild isolated rash still needs prompt assessment because early serious reactions may begin with limited skin changes. Do not use a self-applied cream to mask a new drug rash before medical review.

Mechanism of action

Purines are natural compounds found in human cells and many foods. Their breakdown produces hypoxanthine, then xanthine, and finally uric acid. Xanthine oxidase catalyses the final steps of this pathway. Allopurinol inhibits xanthine oxidase, so less uric acid enters the bloodstream [1].

Lower uric acid levels reduce the likelihood that monosodium urate crystals will accumulate in joints, soft tissues, or the urinary tract. Once sustained urate reduction is achieved, the body can gradually dissolve existing deposits. The process takes time, especially when gout has been present for several years.

Common mistakes

Poor results often come from practical errors rather than a failure of the medicine itself.

  • Stopping Allopurinol during the first flare without a replacement plan.
  • Taking tablets only when joint pain appears.
  • Doubling the next dose after a missed tablet.
  • Starting a new diuretic, antibiotic, or supplement without checking for interactions.
  • Ignoring a new rash because it seems minor.
  • Using ibuprofen despite kidney disease, anticoagulant treatment, or a previous ulcer.
  • Assuming that a normal-feeling joint proves urate levels are controlled.
  • Forgetting to mention Allopurinol before chemotherapy or a hospital admission.
  • Treating an infected joint as routine gout without checking for fever or systemic symptoms.
Keep the medicine list current when a new prescription is added. The combination of Allopurinol with azathioprine or mercaptopurine needs special handling and should never be adjusted independently.

Comparison

Allopurinol is an oral, single-ingredient xanthine oxidase inhibitor that reduces uric acid production. Its role is long-term prevention of urate crystal formation and uric acid stone formation, rather than immediate relief of an acute gout attack. The tablet approach differs from treatments aimed at short-term symptom relief because it works by reducing uric acid generation over time.

What doctors say

In clinical practice, doctors usually frame Allopurinol as a target-based preventive treatment. The aim is sustained urate reduction, not simply fewer painful days. Blood urate results, kidney function, flare history, and adherence all influence treatment decisions.

A common prescribing mistake is starting with an unnecessarily high regimen in a person with reduced renal function. A careful clinician begins with the regimen suited to the chosen strength and health profile, then reviews results before making changes.

Doctors also explain that symptom improvement and biochemical improvement do not always occur on the same schedule. A patient may have fewer attacks before all deposits have dissolved, while another may experience early flares despite a falling urate level. The treatment response is judged across time, laboratory results, and clinical events rather than by one difficult week.

The European Medicines Agency, the U.S. Food and Drug Administration, and NICE describe allopurinol’s role through xanthine oxidase inhibition and uric acid reduction. This mechanism explains why regular administration matters even when symptoms are absent [3].

What customers often ask

Can alcohol be used while taking Allopurinol?

Alcohol can increase uric acid production and may worsen dehydration, which can make gout control more difficult. Beer and spirits are often associated with a higher gout burden, while any alcohol may affect individual symptoms. The TGA product information from 2025 and WHO guidance support discussing alcohol intake as part of urate management rather than treating Allopurinol as protection against dietary triggers. A flare, vomiting, or poor fluid intake is a reason to avoid alcohol until recovery.

What is the best time of day to take Allopurinol?

The best time is the time that supports consistent daily use and matches the prescribed regimen. Taking the tablet after food may help people who experience stomach upset. The TGA product information from 2025 describes oral administration, while clinical practice commonly links timing to adherence and renal considerations rather than to a universal morning or evening rule. Do not change the schedule or divide doses unless the treatment plan allows it.

Can Allopurinol be used during pregnancy or breastfeeding?

Pregnancy and breastfeeding require an individual risk assessment because the benefits of urate control must be weighed against available treatment information. Do not start, stop, or change Allopurinol after becoming pregnant without a clinician’s direction. The TGA product information from 2025 and WHO pharmacovigilance principles support reviewing every medicine during pregnancy and lactation. Provide a complete list of medicines before treatment decisions are made.

Which symptoms mean stopping Allopurinol and seeking urgent medical care?

A widespread rash, blistering, skin peeling, mouth or eye ulcers, facial swelling, fever, breathing difficulty, dark urine, or yellow skin can indicate a serious reaction. Urgent assessment is also needed for severe weakness, unusual bruising, reduced urine, or a painful joint with fever. The EMA safety information from 2024 identifies severe cutaneous reactions and systemic hypersensitivity as urgent risks. Do not take another dose after a suspected severe reaction until a clinician has assessed the situation.

Is Allopurinol suitable for older adults?

Older adults can use Allopurinol when the indication is appropriate, but kidney function, liver function, hydration, and interacting medicines need careful review. Renal clearance may be reduced even when the person feels well, so the starting regimen may need to be lower. TGA prescribing information from 2025 and geriatric medicine practice support gradual, monitored treatment in this group. New rash, confusion, severe diarrhoea, or reduced urine should receive prompt attention.

Can Allopurinol be combined with other medicines or supplements?

The highest-risk combinations include Allopurinol with azathioprine or mercaptopurine because blood-cell suppression can become severe without specialist dose adjustment. Warfarin, theophylline, ACE inhibitors, thiazide diuretics, and some antibiotics also deserve review. WHO medication-safety principles from 2024 support checking the full medicine and supplement list whenever treatment changes. Do not add a supplement marketed for gout or kidney health without assessing its ingredients and kidney effects.

Do you offer anonymous delivery?

Your order will be securely packed and shipped within 24 hours. This is exactly what your package will look like (images of an actual item sent). It has the size and look of a regular private letter (24x11x0.7 cm) and its contents cannot be seen.

Comparison

Allopurinol Current

Active ingredient: Allopurinol
300mg 100mg
From $ 149.52
pills
3.5 (5)

Colchicine

Active ingredient: Colchicine
0.5mg
From $ 195.80
pills
4.2 (3)

How the medicines for Gout compare

Sources

  1. TGA (2024). Product Information — Allopurinol tablets
  2. EMA (2023). Summary of Product Characteristics (SmPC) — allopurinol
  3. FDA (2023). Prescribing Information — Zyloprim (allopurinol)

How Buyers Rate Allopurinol

Based on 5 reviews

Neil, 38 Verified
Rating: 3.5 out of 5

no city, took the prescribed tablet regimen for several months. He reported fewer night-time attacks after the early adjustment period, although the first flare made him worry that treatment was making things worse.

Several months 26 Oct 2026
Jonathan, 59 Verified
Rating: 3.5 out of 5

no city, had used Allopurinol during long-term gout management. His urate results improved after regular dosing, but he needed a regimen review when kidney function changed.

Long-term 10 Oct 2026
Kevin, 28 Verified
Rating: 4.5 out of 5

no city, started treatment after recurrent uric acid stones. He found the tablet easy to take and had no further severe pain during the following months, though he needed reminders to maintain his daily routine.

The following months 13 Oct 2026
Ian, 54 Verified
Rating: 2.5 out of 5

no city, developed a rash soon after starting Allopurinol. He stopped further doses after receiving urgent medical advice and required a different treatment plan.

Soon after starting 5 Nov 2026
John, 35 Verified
Rating: 3.5 out of 5

no city, experienced a flare during the first weeks. He continued the preventive treatment with a separately prescribed anti-inflammatory plan and later reported better control, but the initial period was uncomfortable.

The first weeks 21 Oct 2026
Get our free app Shop faster and track your orders 3.8 · 494 reviews Install